MD Anderson and Xencor enter strategic collaboration to advance investigational XmAb® drug candidates

(University of Texas M. D. Anderson Cancer Center) The University of Texas MD Anderson Cancer Center and Xencor, Inc. today announced a strategic collaboration to study investigational treatments for patients with a variety of cancer types.